{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:30:44Z","timestamp":1789842644666,"version":"4.0.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s10072-019-3720-3","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T00:06:10Z","timestamp":1548374770000},"page":"801-811","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Expression analysis of long non-coding RNAs and their target genes in multiple sclerosis patients"],"prefix":"10.1007","volume":"40","author":[{"given":"Maziar","family":"Ganji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezou","family":"Sayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir Davood","family":"Omrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahram","family":"Arsang-Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdokht","family":"Mazdeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8381-0591","authenticated-orcid":false,"given":"Mohammad","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,24]]},"reference":[{"key":"3720_CR1","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3389\/fimmu.2017.00652","volume":"8","author":"D PILLI","year":"2017","unstructured":"PILLI D, ZOU A, TEA F, DALE RC, BRILOT F (2017) Expanding role of T cells in human autoimmune diseases of the central nervous system. Front Immunol 8:652","journal-title":"Front Immunol"},{"key":"3720_CR2","doi-asserted-by":"crossref","unstructured":"RIEDHAMMER C, WEISSERT R (2015) Antigen presentation, autoantigens, and immune regulation in multiple sclerosis and other autoimmune diseases. Front Immunol 6","DOI":"10.3389\/fimmu.2015.00322"},{"key":"3720_CR3","first-page":"34","volume":"16","author":"MA SAHRAIAN","year":"2017","unstructured":"SAHRAIAN MA, SAHEBKAR M, DEHGHANI R, DERAKHSHAN-JAZARI M, KAZAMI-MOGHADDAM V, KOUCHAKI E (2017) Multiple sclerosis-a disease on a dramatically rising trend in Iran: review of possible reasons. Iran J Neurolt 16:34","journal-title":"Iran J Neurolt"},{"key":"3720_CR4","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri3871","volume":"15","author":"CA DENDROU","year":"2015","unstructured":"DENDROU CA, FUGGER L, FRIESE MA (2015) Immunopathology of multiple sclerosis. Nat Rev Immunol 15:545\u2013558","journal-title":"Nat Rev Immunol"},{"key":"3720_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/cei.12878","volume":"187","author":"A JONES","year":"2017","unstructured":"JONES A, KERMODE A, LUCAS R, CARROLL W, NOLAN D, HART P (2017) Circulating immune cells in multiple sclerosis. Clin Exp Immunol 187:193\u2013203","journal-title":"Clin Exp Immunol"},{"key":"3720_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/cyto.a.22348","volume":"85","author":"L COSMI","year":"2014","unstructured":"COSMI L, MAGGI L, SANTARLASCI V, LIOTTA F, ANNUNZIATO F (2014) T helper cells plasticity in inflammation. Cytometry Part A 85:36\u201342","journal-title":"Cytometry Part A"},{"key":"3720_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","volume":"74","author":"I RAPHAEL","year":"2015","unstructured":"RAPHAEL I, NALAWADE S, EAGAR TN, FORSTHUBER TG (2015) T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine 74:5\u201317","journal-title":"Cytokine"},{"key":"3720_CR8","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1096\/fj.14-260323","volume":"29","author":"JL MARQUES-ROCHA","year":"2015","unstructured":"MARQUES-ROCHA JL, SAMBLAS M, MILAGRO FI, BRESSAN J, MART\u00cdNEZ JA, MARTI A (2015) Noncoding RNAs, cytokines, and inflammation-related diseases. FASEB J 29:3595\u20133611","journal-title":"FASEB J"},{"key":"3720_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/861231","volume":"2014","author":"G OLMOS","year":"2014","unstructured":"OLMOS G, LLAD\u00d3 J (2014) Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity. Mediat Inflamm 2014:1\u201312","journal-title":"Mediat Inflamm"},{"key":"3720_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3233\/HAB-160291","volume":"24","author":"M TAHERI","year":"2016","unstructured":"TAHERI M, NEMATI S, MOVAFAGH A, SABERI M, MIRFAKHRAIE R, EFTEKHARIAN MM, ARSANG-JANG S, REZAGHOLIZADEH A, SAYAD A (2016) TRAIL gene expression analysis in multiple sclerosis patients. Hum Antibodies 24:33\u201338","journal-title":"Hum Antibodies"},{"key":"3720_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s12031-017-0982-1","volume":"63","author":"MM EFTEKHARIAN","year":"2017","unstructured":"EFTEKHARIAN MM, GHAFOURI-FARD S, SOUDYAB M, OMRANI MD, RAHIMI M, SAYAD A, KOMAKI A, MAZDEH M, TAHERI M (2017) Expression analysis of long non-coding RNAs in the blood of multiple sclerosis patients. J Mol Neurosci 63:333\u2013341","journal-title":"J Mol Neurosci"},{"key":"3720_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s12031-016-0741-8","volume":"59","author":"M SANTORO","year":"2016","unstructured":"SANTORO M, NOCITI V, LUCCHINI M, DE FINO C, LOSAVIO FA, MIRABELLA M (2016) Expression profile of long non-coding RNAs in serum of patients with multiple sclerosis. J Mol Neurosci 59:18\u201323","journal-title":"J Mol Neurosci"},{"key":"3720_CR13","doi-asserted-by":"crossref","unstructured":"WANG A, WANG J, LIU Y, ZHOU Y (2017) Mechanisms of long non-coding RNAs in the assembly and plasticity of neural circuitry. Front Neural Circuits 11","DOI":"10.3389\/fncir.2017.00076"},{"key":"3720_CR14","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/cns.12498","volume":"22","author":"F ZHANG","year":"2016","unstructured":"ZHANG F, GAO C, MA XF, PENG XL, ZHANG RX, KONG DX, SIMARD AR, HAO JW (2016) Expression profile of long noncoding RNAs in peripheral blood mononuclear cells from multiple sclerosis patients. CNS Neurosci Ther 22:298\u2013305","journal-title":"CNS Neurosci Ther"},{"key":"3720_CR15","doi-asserted-by":"publisher","first-page":"E3883","DOI":"10.1073\/pnas.1501662112","volume":"112","author":"Y WANG","year":"2015","unstructured":"WANG Y, ZHONG H, XIE X, CHEN CY, HUANG D, SHEN L, ZHANG H, CHEN ZW, ZENG G (2015b) Long noncoding RNA derived from CD244 signaling epigenetically controls CD8+ T-cell immune responses in tuberculosis infection. Proc Natl Acad Sci 112:E3883\u2013E3892","journal-title":"Proc Natl Acad Sci"},{"key":"3720_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1189\/jlb.1RI0815-389R","volume":"99","author":"TM AUNE","year":"2016","unstructured":"AUNE TM, CROOKE PS, SPURLOCK CF (2016) Long noncoding RNAs in T lymphocytes. J Leukoc Biol 99:31\u201344","journal-title":"J Leukoc Biol"},{"key":"3720_CR17","doi-asserted-by":"crossref","unstructured":"PENG H, LIU Y, TIAN J, MA J, TANG X, RUI K, TIAN X, MAO C, LU L, XU H (2015) The long noncoding RNA IFNG-AS1 promotes T helper type 1 cells response in patients with Hashimoto\u2019s thyroiditis. Sci Rep 5","DOI":"10.1038\/srep17702"},{"key":"3720_CR18","doi-asserted-by":"publisher","first-page":"5632","DOI":"10.1128\/JVI.77.10.5632-5638.2003","volume":"77","author":"S VIGNEAU","year":"2003","unstructured":"VIGNEAU S, ROHRLICH P-S, BRAHIC M, BUREAU J-F (2003) Tmevpg1, a candidate gene for the control of Theiler\u2019s virus persistence, could be implicated in the regulation of gamma interferon. J Virol 77:5632\u20135638","journal-title":"J Virol"},{"key":"3720_CR19","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.4049\/jimmunol.1200774","volume":"189","author":"SP COLLIER","year":"2012","unstructured":"COLLIER SP, COLLINS PL, WILLIAMS CL, BOOTHBY MR, AUNE TM (2012) Cutting edge: influence of Tmevpg1, a long intergenic noncoding RNA, on the expression of Ifng by Th1 cells. J Immunol 189:2084\u20132088","journal-title":"J Immunol"},{"key":"3720_CR20","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.4049\/jimmunol.1401099","volume":"193","author":"SP COLLIER","year":"2014","unstructured":"COLLIER SP, HENDERSON MA, TOSSBERG JT, AUNE TM (2014) Regulation of the Th1 genomic locus from Ifng through Tmevpg1 by T-bet. J Immunol 193:3959\u20133965","journal-title":"J Immunol"},{"key":"3720_CR21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.18071\/isz.71.0321","volume":"71","author":"T CSEPANY","year":"2018","unstructured":"CSEPANY T (2018) Diagnosis of multiple sclerosis: a review of the 2017 revisions of the McDonald criteria. Ideggyogy Sz 71:321\u2013329","journal-title":"Ideggyogy Sz"},{"key":"3720_CR22","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s10072-017-2935-4","volume":"38","author":"A SAYAD","year":"2017","unstructured":"SAYAD A, GHAFOURI-FARD S, OMRANI MD, NOROOZI R, TAHERI M (2017) Myxovirus resistance protein A (MxA) polymorphism is associated with IFN\u03b2 response in Iranian multiple sclerosis patients. Neurol Sci 38:1093\u20131099","journal-title":"Neurol Sci"},{"key":"3720_CR23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.cyto.2017.04.007","volume":"96","author":"M TAHERI","year":"2017","unstructured":"TAHERI M, GHAFOURI-FARD S, SOLGI G, SAYAD A, MAZDEH M, OMRANI MD (2017) Determination of cytokine levels in multiple sclerosis patients and their relevance with patients\u2019 response to Cinnovex. Cytokine 96:138\u2013143","journal-title":"Cytokine"},{"key":"3720_CR24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2217\/pgs.16.2","volume":"17","author":"M MAZDEH","year":"2016","unstructured":"MAZDEH M, TAHERI M, SAYAD A, BAHRAM S, OMRANI MD, MOVAFAGH A, INOKO H, AKBARI MT, NOROOZI R, HAJILOOI M, SOLGI G (2016) HLA genes as modifiers of response to IFN-beta-1a therapy in relapsing-remitting multiple sclerosis. Pharmacogenomics 17:489\u2013498","journal-title":"Pharmacogenomics"},{"key":"3720_CR25","doi-asserted-by":"publisher","first-page":"E3883","DOI":"10.1073\/pnas.1501662112","volume":"112","author":"Y WANG","year":"2015","unstructured":"WANG Y, ZHONG H, XIE X, CHEN CY, HUANG D, SHEN L, ZHANG H, CHEN ZW, ZENG G (2015a) Long noncoding RNA derived from CD244 signaling epigenetically controls CD8+ T-cell immune responses in tuberculosis infection. Proc Natl Acad Sci U S A 112:E3883\u2013E3892","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3720_CR26","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1600-0404.1988.tb03663.x","volume":"78","author":"J BECK","year":"1988","unstructured":"BECK J, RONDOT P, CATINOT L, FALCOFF E, KIRCHNER H, WIETZERBIN J (1988) Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand 78:318\u2013323","journal-title":"Acta Neurol Scand"},{"key":"3720_CR27","first-page":"523","volume":"3","author":"M CHOFFLON","year":"1992","unstructured":"CHOFFLON M, JUILLARD C, JUILLARD P, GAUTHIER G, GRAU GE (1992) Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis. Eur Cytokine Netw 3:523\u2013531","journal-title":"Eur Cytokine Netw"},{"key":"3720_CR28","first-page":"253","volume":"8","author":"M CHOFFLON","year":"1997","unstructured":"CHOFFLON M, ROTH S, JUILLARD C, PAUNIER A, JUILLARD P, DEGROOTE D, GRAU G (1997) Tumor necrosis factor production capacity as a potentially useful parameter to monitor disease activity in multiple sclerosis. Eur Cytokine Netw 8:253\u2013257","journal-title":"Eur Cytokine Netw"},{"key":"3720_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/135245859800400320","volume":"4","author":"J DEBRUYNE","year":"1998","unstructured":"DEBRUYNE J, PHILIPP\u00c9 J, DEREUCK J, WILLEMS A, LEROUX-ROELS G (1998) Relapse markers in multiple sclerosis: are in vitro cytokine production changes reflected by circulatory T-cell phenotype alterations? Mult Scler J 4:193\u2013197","journal-title":"Mult Scler J"},{"key":"3720_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/0891693031000089427","volume":"36","author":"RD HOLLIFIELD","year":"2003","unstructured":"HOLLIFIELD RD, HARBIGE LS, PHAM-DINH D, SHARIEF MK (2003) Evidence for cytokine dysregulation in multiple sclerosis: peripheral blood mononuclear cell production of pro-inflammatory and anti-inflammatory cytokines during relapse and remission. Autoimmunity 36:133\u2013141","journal-title":"Autoimmunity"},{"key":"3720_CR31","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1136\/jnnp-2013-307336","volume":"86","author":"S SIMPSON","year":"2015","unstructured":"SIMPSON S, STEWART N, VAN DER MEI I, OTAHAL P, CHARLESWORTH J, PONSONBY A-L, BLIZZARD L, DWYER T, PITTAS F, GIES P (2015) Stimulated PBMC-produced IFN-\u03b3 and TNF-\u03b1 are associated with altered relapse risk in multiple sclerosis: results from a prospective cohort study. J Neurol Neurosurg Psychiatry 86:200\u2013207","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3720_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12017-014-8298-6","volume":"17","author":"C\u0130 K\u00dc\u00c7\u00dcKALI","year":"2015","unstructured":"K\u00dc\u00c7\u00dcKALI C\u0130, K\u00dcRT\u00dcNC\u00dc M, \u00c7OBAN A, \u00c7EBI M, T\u00dcZ\u00dcN E (2015) Epigenetics of multiple sclerosis: an updated review. NeuroMolecular Med 17:83\u201396","journal-title":"NeuroMolecular Med"},{"key":"3720_CR33","doi-asserted-by":"crossref","unstructured":"KULAR L, CASTELO-BRANCO G, JAGODIC M (2017) Epigenetics and multiple sclerosis. In: Neuropsychiatric disorders and epigenetics. Elsevier","DOI":"10.1016\/B978-0-12-800226-1.00010-1"},{"key":"3720_CR34","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/nsmb.2428","volume":"19","author":"S GUIL","year":"2012","unstructured":"GUIL S, ESTELLER M (2012) Cis-acting noncoding RNAs: friends and foes. Nat Struct Mol Biol 19:1068\u20131075","journal-title":"Nat Struct Mol Biol"},{"key":"3720_CR35","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.cell.2011.03.014","volume":"145","author":"T NAGANO","year":"2011","unstructured":"NAGANO T, FRASER P (2011) No-nonsense functions for long noncoding RNAs. Cell 145:178\u2013181","journal-title":"Cell"},{"key":"3720_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nri.2016.123","volume":"17","author":"B BECHER","year":"2017","unstructured":"BECHER B, SPATH S, GOVERMAN J (2017) Cytokine networks in neuroinflammation. Nat Rev Immunol 17:49\u201359","journal-title":"Nat Rev Immunol"},{"key":"3720_CR37","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nri2550","volume":"9","author":"J GOVERMAN","year":"2009","unstructured":"GOVERMAN J (2009) Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9:393\u2013407","journal-title":"Nat Rev Immunol"},{"key":"3720_CR38","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/0303-8467(96)00041-8","volume":"98","author":"J PHILIPP\u00c9","year":"1996","unstructured":"PHILIPP\u00c9 J, DEBRUYNE J, LEROUX-ROELS G, WILLEMS A, DEREUCK J (1996) In vitro TNF-\u03b1, IL-2 and IFN-\u03b3 production as markers of relapses in multiple sclerosis. Clin Neurol Neurosurg 98:286\u2013290","journal-title":"Clin Neurol Neurosurg"},{"key":"3720_CR39","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1001\/archneur.55.6.793","volume":"55","author":"BW VAN OOSTEN","year":"1998","unstructured":"VAN OOSTEN BW, BARKHOF F, SCHOLTEN PE, VON BLOMBERG BME, AD\u00c8R HJ, POLMAN CH (1998) Increased production of tumor necrosis factor \u03b1, and not of interferon \u03b3, preceding disease activity in patients with multiple sclerosis. Arch Neurol 55:793\u2013798","journal-title":"Arch Neurol"},{"key":"3720_CR40","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.cell.2013.01.015","volume":"152","author":"JA GOMEZ","year":"2013","unstructured":"GOMEZ JA, WAPINSKI OL, YANG YW, BUREAU J-F, GOPINATH S, MONACK DM, CHANG HY, BRAHIC M, KIRKEGAARD K (2013) The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-\u03b3 locus. Cell 152:743\u2013754","journal-title":"Cell"},{"key":"3720_CR41","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3109\/08916934.2016.1167192","volume":"49","author":"H LI","year":"2016","unstructured":"LI H, HAO Y, ZHANG D, FU R, LIU W, ZHANG X, XUE F, YANG R (2016) Aberrant expression of long noncoding RNA TMEVPG1 in patients with primary immune thrombocytopenia. Autoimmunity 49:496\u2013502","journal-title":"Autoimmunity"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-019-3720-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-3720-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-3720-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T19:14:19Z","timestamp":1579806859000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-019-3720-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,24]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["3720"],"URL":"https:\/\/doi.org\/10.1007\/s10072-019-3720-3","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,24]]},"assertion":[{"value":"2 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}